-
BraTS-Path Challenge: Assessing Heterogeneous Histopathologic Brain Tumor Sub-regions
Authors:
Spyridon Bakas,
Siddhesh P. Thakur,
Shahriar Faghani,
Mana Moassefi,
Ujjwal Baid,
Verena Chung,
Sarthak Pati,
Shubham Innani,
Bhakti Baheti,
Jake Albrecht,
Alexandros Karargyris,
Hasan Kassem,
MacLean P. Nasrallah,
Jared T. Ahrendsen,
Valeria Barresi,
Maria A. Gubbiotti,
Giselle Y. López,
Calixto-Hope G. Lucas,
Michael L. Miller,
Lee A. D. Cooper,
Jason T. Huse,
William R. Bell
Abstract:
Glioblastoma is the most common primary adult brain tumor, with a grim prognosis - median survival of 12-18 months following treatment, and 4 months otherwise. Glioblastoma is widely infiltrative in the cerebral hemispheres and well-defined by heterogeneous molecular and micro-environmental histopathologic profiles, which pose a major obstacle in treatment. Correctly diagnosing these tumors and as…
▽ More
Glioblastoma is the most common primary adult brain tumor, with a grim prognosis - median survival of 12-18 months following treatment, and 4 months otherwise. Glioblastoma is widely infiltrative in the cerebral hemispheres and well-defined by heterogeneous molecular and micro-environmental histopathologic profiles, which pose a major obstacle in treatment. Correctly diagnosing these tumors and assessing their heterogeneity is crucial for choosing the precise treatment and potentially enhancing patient survival rates. In the gold-standard histopathology-based approach to tumor diagnosis, detecting various morpho-pathological features of distinct histology throughout digitized tissue sections is crucial. Such "features" include the presence of cellular tumor, geographic necrosis, pseudopalisading necrosis, areas abundant in microvascular proliferation, infiltration into the cortex, wide extension in subcortical white matter, leptomeningeal infiltration, regions dense with macrophages, and the presence of perivascular or scattered lymphocytes. With these features in mind and building upon the main aim of the BraTS Cluster of Challenges https://www.synapse.org/brats2024, the goal of the BraTS-Path challenge is to provide a systematically prepared comprehensive dataset and a benchmarking environment to develop and fairly compare deep-learning models capable of identifying tumor sub-regions of distinct histologic profile. These models aim to further our understanding of the disease and assist in the diagnosis and grading of conditions in a consistent manner.
△ Less
Submitted 17 May, 2024;
originally announced May 2024.
-
Federated Learning for the Classification of Tumor Infiltrating Lymphocytes
Authors:
Ujjwal Baid,
Sarthak Pati,
Tahsin M. Kurc,
Rajarsi Gupta,
Erich Bremer,
Shahira Abousamra,
Siddhesh P. Thakur,
Joel H. Saltz,
Spyridon Bakas
Abstract:
We evaluate the performance of federated learning (FL) in developing deep learning models for analysis of digitized tissue sections. A classification application was considered as the example use case, on quantifiying the distribution of tumor infiltrating lymphocytes within whole slide images (WSIs). A deep learning classification model was trained using 50*50 square micron patches extracted from…
▽ More
We evaluate the performance of federated learning (FL) in developing deep learning models for analysis of digitized tissue sections. A classification application was considered as the example use case, on quantifiying the distribution of tumor infiltrating lymphocytes within whole slide images (WSIs). A deep learning classification model was trained using 50*50 square micron patches extracted from the WSIs. We simulated a FL environment in which a dataset, generated from WSIs of cancer from numerous anatomical sites available by The Cancer Genome Atlas repository, is partitioned in 8 different nodes. Our results show that the model trained with the federated training approach achieves similar performance, both quantitatively and qualitatively, to that of a model trained with all the training data pooled at a centralized location. Our study shows that FL has tremendous potential for enabling development of more robust and accurate models for histopathology image analysis without having to collect large and diverse training data at a single location.
△ Less
Submitted 31 March, 2022; v1 submitted 30 March, 2022;
originally announced March 2022.
-
GaNDLF: A Generally Nuanced Deep Learning Framework for Scalable End-to-End Clinical Workflows in Medical Imaging
Authors:
Sarthak Pati,
Siddhesh P. Thakur,
İbrahim Ethem Hamamcı,
Ujjwal Baid,
Bhakti Baheti,
Megh Bhalerao,
Orhun Güley,
Sofia Mouchtaris,
David Lang,
Spyridon Thermos,
Karol Gotkowski,
Camila González,
Caleb Grenko,
Alexander Getka,
Brandon Edwards,
Micah Sheller,
Junwen Wu,
Deepthi Karkada,
Ravi Panchumarthy,
Vinayak Ahluwalia,
Chunrui Zou,
Vishnu Bashyam,
Yuemeng Li,
Babak Haghighi,
Rhea Chitalia
, et al. (17 additional authors not shown)
Abstract:
Deep Learning (DL) has the potential to optimize machine learning in both the scientific and clinical communities. However, greater expertise is required to develop DL algorithms, and the variability of implementations hinders their reproducibility, translation, and deployment. Here we present the community-driven Generally Nuanced Deep Learning Framework (GaNDLF), with the goal of lowering these…
▽ More
Deep Learning (DL) has the potential to optimize machine learning in both the scientific and clinical communities. However, greater expertise is required to develop DL algorithms, and the variability of implementations hinders their reproducibility, translation, and deployment. Here we present the community-driven Generally Nuanced Deep Learning Framework (GaNDLF), with the goal of lowering these barriers. GaNDLF makes the mechanism of DL development, training, and inference more stable, reproducible, interpretable, and scalable, without requiring an extensive technical background. GaNDLF aims to provide an end-to-end solution for all DL-related tasks in computational precision medicine. We demonstrate the ability of GaNDLF to analyze both radiology and histology images, with built-in support for k-fold cross-validation, data augmentation, multiple modalities and output classes. Our quantitative performance evaluation on numerous use cases, anatomies, and computational tasks supports GaNDLF as a robust application framework for deployment in clinical workflows.
△ Less
Submitted 16 May, 2023; v1 submitted 25 February, 2021;
originally announced March 2021.
